Andrx Pharmaceuticals, LLC v. GlaxoSmithKline, PLC
You are here: Home »
The law firm of Isicoff Ragatz & Koenigsberg (Miami) retained our consultants, on behalf of the plaintiff, with regard to case no. 05-CV-23264 in the USDC for the Southern District of Florida, to provide an opinion of damages arising from the alleged infringement of U.S. patent 6,905,708 titled, Controlled Release Oral Dosage Form.
Hampton IP Expert Services
We provided lost profit and reasonable royalty damage analyses, submitted a Rule 26 expert report and gave deposition testimony.
Verdict
The case settled favorably for Andrx.
Practice Area
Patent Damage
Plaintif
Andrx Pharmaceutical
Defendant
GlaxoSmithKline
Property
Extended release anti-depressant
Industry
Pharmaceutical
Location
Miami